tiprankstipranks
Phreesia (PHR)
NYSE:PHR
US Market

Phreesia (PHR) Earnings Dates, Call Summary & Reports

367 Followers

Earnings Data

Report Date
May 28, 2026
After Close (Confirmed)
Period Ending
2027 (Q1)
Consensus EPS Forecast
0.01
Last Year’s EPS
-0.07
Same Quarter Last Year
Moderate Buy
Based on 16 Analysts Ratings

Earnings Call Summary

Q4 2026
Earnings Call Date:Mar 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call highlights substantial progress on profitability and cash generation (first full-year positive GAAP net income, >$100M Adjusted EBITDA, >$50M free cash flow) and successful financing and acquisition integration (AccessOne performing as expected). Management preserved fiscal 2027 Adjusted EBITDA guidance and emphasized AI-driven efficiency opportunities. However, the company reduced fiscal 2027 revenue guidance due to shorter visibility and reduced commitments from certain pharmaceutical clients (notably vaccines and some public health spend), creating variability concentrated in the higher-margin Network Solutions segment. New initiatives (ProviderConnect) and AccessOne expansion offer upside but remain early-stage. Overall, the results show meaningful financial strength and execution, offset by near-term top-line uncertainty in a key segment.
Company Guidance
Phreesia updated fiscal 2027 guidance, lowering revenue to $510.0M–$520.0M (prior range $545.0M–$559.0M) while maintaining Adjusted EBITDA of $125.0M–$135.0M; the company expects AHSC growth in the mid-single-digit percent range and total revenue per AHSC to grow in the low-single-digit percent range (vs. prior low-double-digit expectation), assumes no incremental revenue from acquisitions through 01/31/2027, and expects payment processing (ex‑AccessOne) to grow in the single digits. Key Q4/FY26 metrics cited on the call included Q4 revenue $127.1M (up 16% YoY; +7% ex‑AccessOne), Q4 Adjusted EBITDA $29.4M (23% margin), Q4 net cash from operations $33.7M (+$17.4M YoY), Q4 free cash flow $28.5M (+$19.3M YoY), FY26 milestones of >$100M Adjusted EBITDA, >$50M free cash flow and positive GAAP net income, Q4 AHSCs 4,658 (+138 QoQ; 80 from AccessOne) with Q4 total revenue per AHSC $27,279 (+8% YoY), cash & equivalents $73.8M (01/31/2026), and the March refinancing: $275M senior secured revolver (maturity 03/13/2031) with $92M drawn to repay the bridge loan and unused capacity available for working capital, capex, M&A and potential share repurchases or debt paydown.
Quarterly Revenue Growth
Q4 revenue was $127.1M, up 16% year-over-year; excluding the AccessOne acquisition, revenue grew 7% YoY.
Strong Adjusted EBITDA Performance
Q4 Adjusted EBITDA was $29.4M versus $16.4M in the prior-year period (≈+79% YoY), representing an Adjusted EBITDA margin of 23%.
Key Annual Profitability and Cash Milestones
Fiscal 2026 milestones include surpassing $100.0M in Adjusted EBITDA for the year, crossing $50.0M in free cash flow for the year, and delivering positive GAAP net income for the full fiscal year for the first time as a public company.
Record Quarterly Free Cash Flow and Operating Cash Flow Improvement
Q4 net cash provided by operating activities was $33.7M, up $17.4M YoY; Q4 free cash flow was $28.5M, up $19.3M YoY and the strongest quarterly FCF to date.
Client Base and Revenue per Client Expansion
Average healthcare services clients (AHSCs) reached 4,658 in Q4, up 138 sequentially (80 contributed by AccessOne); total revenue per AHSC was $27,279, up 8% YoY.
AccessOne Acquisition Driving Payment Solutions Growth
Payment Solutions led growth in Q4 following the AccessOne acquisition; management reports AccessOne is performing in line with expectations and is a central pillar of provider financing strategy.
Balance Sheet and Financing Execution
Completed refinancing after fiscal year end: new five-year $275M senior secured revolving credit facility (maturing 03/13/2031) with $92M borrowed to repay the bridge loan, providing available capacity for working capital, capex, acquisitions, and potential debt paydown or buybacks.
New Product Launch and AI-Driven Efficiency
Launched ProviderConnect (HCP marketing) in early March as a complementary offering to PatientConnect; company expects meaningful AI-driven operational efficiencies (reducing manual and outsourced processes) contributing to margin expansion.

Phreesia (PHR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PHR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 28, 2026
2027 (Q1)
0.01 / -
-0.07
Mar 30, 2026
2026 (Q4)
0.07 / 0.02
-0.11118.18% (+0.13)
Dec 08, 2025
2026 (Q3)
0.00 / 0.07
-0.25128.00% (+0.32)
Sep 04, 2025
2026 (Q2)
-0.06 / 0.01
-0.31103.23% (+0.32)
May 28, 2025
2026 (Q1)
-0.12 / -0.07
-0.3580.00% (+0.28)
Mar 12, 2025
2025 (Q4)
-0.18 / -0.11
-0.5680.36% (+0.45)
Dec 09, 2024
2025 (Q3)
-0.24 / -0.25
-0.5856.90% (+0.33)
Sep 04, 2024
2025 (Q2)
-0.35 / -0.31
-0.6854.41% (+0.37)
May 30, 2024
2025 (Q1)
-0.47 / -0.35
-0.750.00% (+0.35)
Mar 14, 2024
2024 (Q4)
-0.56 / -0.56
-0.7222.22% (+0.16)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

PHR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 30, 2026
$11.41$8.38-26.56%
Dec 08, 2025
$20.12$15.43-23.31%
Sep 04, 2025
$31.21$28.13-9.87%
May 28, 2025
$24.95$23.30-6.61%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Phreesia (PHR) report earnings?
Phreesia (PHR) is schdueled to report earning on May 28, 2026, After Close (Confirmed).
    What is Phreesia (PHR) earnings time?
    Phreesia (PHR) earnings time is at May 28, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PHR EPS forecast?
          PHR EPS forecast for the fiscal quarter 2027 (Q1) is 0.01.